ESC 365 - Effect of pulmonary arterial hypertension specific therapy in the four clinical subgroups of patients with pulmonary arterial hypertension associated with congenital heart disease

ESC Premium Access

Effect of pulmonary arterial hypertension specific therapy in the four clinical subgroups of patients with pulmonary arterial hypertension associated with congenital heart disease

Session: Poster Session 4 - Acute and chronic pulmonary hypertension : treatment

Topic: Pulmonary Hypertension

Speaker: Doctor D. Guarino (Bologna, IT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Daniele Guarino

S. Orsola-Malpighi Policlinic, Bologna (Italy)

0 follower

9 more presentations in this session

Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: results from a multidisciplinary multicenter prospective registry

Speaker: Doctor R. Chopard (Besancon, FR)

Non-recommended dosing of direct oral anticoagulants in acute pulmonary embolism is related to an increased rate of adverse events at 6 months: results of a prospective regional multicenter registry

Speaker: Doctor G. Serzian (Besancon, FR)

Extracorporeal membrane oxygenation in patients with pulmonary embolism

Speaker: Professor N. Meneveau (Besancon, FR)

Transthoracic pulmonary artery denervation attenuates the progression of pulmonary arterial hypertension in a rat model

Speaker: Doctor Y. Huang (Beijing, CN)

Comparison of cardiac output measurement methods for mortality prediction in pulmonary hypertension

Speaker: Doctor E. Simsek (Izmir, TR)

Access the full session

Poster Session 4 - Acute and chronic pulmonary hypertension : treatment

Speakers: Doctor D. Guarino, Doctor R. Chopard, Doctor G. Serzian, Professor N. Meneveau, Doctor Y. Huang...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources